title: Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat.
abstract: BACKGROUND
  Increased sympathetic activity contributes to the progression of heart failure. Adenosine counteracts sympathetic activity by inhibition of presynaptic norepinephrine release and attenuation of the metabolic and contractile responses to beta-adrenergic stimulation. In this study, we tested the hypothesis that the adenosinergic effects (uptake blockade) of dipyridamole may retard the progression of pressure overload hypertrophy in the rat.
  
  
  RESULTS
  To verify that the administration of dipyridamole increases myocardial adenosine levels in the rat, epicardial adenosine concentrations were measured from 12 isolated, perfused rat hearts exposed to 10(-7) and 10(-6) mol/l dipyridamole. Adenosine concentrations were increased with both doses of dipyridamole. Also, 9 weeks of dipyridamole treatment resulted in decreased sensitivity to the adenosine A1-receptor agonist, 2-chloro-N6-cyclopentyl adenosine, suggesting that dipyridamole increases adenosine levels in the intact rat. In the second part of the study, rats were divided into either abdominal aortic-banded or sham-operated groups and were treated with either dipyridamole or saline. After 9 weeks of treatment, two-dimensional Doppler echocardiographic studies were performed and the adrenergic responsiveness to 10(-8) mol/l isoproterenol was assessed in vitro. The saline-treated banded group demonstrated concentric left ventricular hypertrophy, abnormal diastolic filling, increased wet lung weights and attenuation of adrenergic responsiveness. In contrast, the dipyridamole-treated banded rats exhibited more concentric geometry (higher relative wall thickness with similar left ventricular mass), normal left ventricular filling characteristics and preserved adrenergic responsiveness. Systolic left ventricular chamber and myocardial function, as assessed by stress-endocardial and midwall shortening relationships, were not significantly altered by banding or dipyridamole treatment.
  
  
  CONCLUSIONS
  Dipyridamole treatment prevented the development of abnormal left ventricular chamber filling, preserved adrenergic responsiveness and appeared to attenuate detrimental chamber remodeling in rats with pressure overload hypertrophy.
authors.affiliation: Department of Medicine, University of Massachusetts Medical Center, Worcester 01655, USA.
authors.forename: E S
authors.initials: ES
authors.lastname: Chung
authors.forename: S
authors.initials: S
authors.lastname: Perlini
authors.forename: G P
authors.initials: GP
authors.lastname: Aurigemma
authors.forename: R A
authors.initials: RA
authors.lastname: Fenton
authors.forename: J G
authors.initials: JG
authors.lastname: Dobson
authors.forename: T E
authors.initials: TE
authors.lastname: Meyer
mesh_terms: D000241:Adenosine / Q000037:antagonists & inhibitors* / Q000097:blood; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D004176:Dipyridamole / Q000494:pharmacology* / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000378:metabolism*; D008168:Lung; D008297:Male; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D009929:Organ Size; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D011943:Receptors, Adrenergic, beta / Q000378:metabolism* / Q000502:physiology; D018047:Receptors, Purinergic P1 / Q000502:physiology; D012680:Sensitivity and Specificity; D013534:Survival; D013599:Systole / Q000187:drug effects / Q000502:physiology; D016277:Ventricular Function, Left / Q000187:drug effects* / Q000502:physiology
chemical_list: D011943:Receptors, Adrenergic, beta; D018047:Receptors, Purinergic P1; D004176:Dipyridamole; D000241:Adenosine